참고문헌
- American Psychiatric Association (1994). Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. (Washington DC: American Psychiatric Association)
- Cacabelos, R., Barquero, M., Garcia, P., Alvarez, X.A., and Varela de Seijas, E. (1991). Cerebrospinal fluid interleukin-1 beta(IL-1 beta) in Alzheimer's disease and neurological disorders. Methods Find. Exp. Clin. Pharmacol. 13, 455-458
- Combarros, O., Sanchez-Guerra, M., Infante, J., Llorca, J., and Berciano, J. (2002). Gene dose-dependent association of interIeukin-1A[-889] allele 2 polymorphism with Alzheimer's disease. J. Neurol. 249,1242-1245 https://doi.org/10.1007/s00415-002-0819-9
- Dominici, R., Cattaneo, M., Malferrari, G., Archi, D., Mariani, C., Grimaldi, L.M., and Biunno, I. (2002). Cloning and functional analysis of the allelic polymorphism in the transcription regulatory region of interleukin-1 alpha. Immunogenetics 54, 82-86 https://doi.org/10.1007/s00251-002-0445-9
- Du, Y., Dodel, R.C., Eastwood, B.J., Bales, K.R., Gao, F., Lohmuller, F., Muller, U., Kurz, A., Zimmer, R., Evans, R.M., Hake, A., Gasser, T., Oertel, W.H., Griffin, W.S., Paul, S.M., and Farlow, M.R. (2000). Association of an interleukin 1 alpha polymorphism with Alzheimer's disease. Neurology 55, 480-483 https://doi.org/10.1212/WNL.55.4.480
- Fidani, L., Goulas, A., Mirtsou, V., Petersen, R.C., Tangalos, E, Crook, R., and Hardy, J. (2002). Interleukin-1A polymorphism is not associated with late onset Alzheimer's disease. Neurosci. Lett. 323, 81-83 https://doi.org/10.1016/S0304-3940(02)00114-3
- Green, E.K., Harris, J.M., Lemmon, H., Lambert, J.C., Chartier-Harlin, M.C., St Clair, D., Mann, D.M., Iwatsubo, T., and Lendon, C.L. (2002). Are interleukin-1 gene polymorphisms risk factors or disease modifiers in AD? Neurology 58,1566-1568 https://doi.org/10.1212/WNL.58.10.1566
- Griffin, W.S., Stanley, L.C., Ling, C., White, L., MacLeod, V., Perrot, L.J., White, C.L. 3rd, and Araoz, C. (1989). Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc. Natl. Acad. Sci. USA 86, 7611-7615 https://doi.org/10.1073/pnas.86.19.7611
- Grimaldi, L.M., Casadei, V.M., Ferri, C., Veglia, F., Licastro, F., Annoni, G., Biunno, I., De Bellis, G., Sorbi, S., Mariani, C., Canal, N., Griffin, W.S., and Franceschi, M. (2000). Association of early-onset Alzheimer's disease with an interleukin-1 alpha gene polymorphism. Ann. Neurol. 47, 361-365 https://doi.org/10.1002/1531-8249(200003)47:3<361::AID-ANA12>3.0.CO;2-N
- Hedley, R., Hallmayer, J., Groth, D.M., Brooks, W.S., Gandy, S.E., and Martins, R.N. (2002). Association of interleukin-1 polymorphisms with Alzheimer's disease in Australia. Ann. Neurol. 51, 795-797 https://doi.org/10.1002/ana.10196
- Howell, W.M., Jobs, M., Gyllensten, U., and Brookes, A.J. (1999). Dynamic allele-specific hybridization. A new method for scoring single nucleotide polymorphisms. Nat Biotechnol. 17, 87-88 https://doi.org/10.1038/5270
- Ki, C.S., Na, D.L., Kim, D.K., Kim, H.J., and Kim, J.W. (2001). Lack of association of the interleukin-1 alpha gene polymorphism with Alzheimer's disease in a Korean population. Ann. Neurol. 49, 817-818
- Kolsch, H., Ptok, U., Bagli, M., Papassotiropoulos, A., Schmitz, S., Barkow, K., Kockler, M., Rao, M.L., Maier, W., and Heun, R. (2001). Gene polymorphisms of interleukin-1alpha influence the course of Alzheimer's disease. Ann. Neurol. 49, 818-819 https://doi.org/10.1002/ana.1068
- Kuo, Y.M., Liao, P.C., Lin, C., Wu, C.W., Huang, H.M., Lin, C.C., and Chuo, L.J. (2003). Lack of association between interleukin-1alpha polymorphism and Alzheimer disease or vascular dementia. Alzheimer Dis, Assoc. Disord. 17, 94-97 https://doi.org/10.1097/00002093-200304000-00007
- Lee, J.H., Lee, K.U., Lee, D.Y., Kim, K.W., Jhoo, J.H., Kim, J.H., Lee, K.H., Kim, S.Y., Han, S.H., and Woo, J.I. (2002). Development of the Korean version of the Consortium to Establish a Registry for Alzheimer's Disease Assessment Packet (CERAD-K): clinical and neuropsychological assessment batteries. J. Gerontol. B. Psychol. Sci. Soc. Sci. 57, 47-53 https://doi.org/10.1093/geronb/57.1.P47
- McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D. and Stadlan, E.M. (1984). Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human services Task Force on Alzheimer's Disease. Neurology 34, 939-944 https://doi.org/10.1212/WNL.34.7.939
- Minster, R.L., DeKosky, S.T., Ganguli, M., Belle, S., and Kamboh, M.I. (2000). Genetic association studies of interleukin-1 (IL-1A and IL-1B)and interleukin-l receptor antagonist genes and the risk of Alzheimer's disease. Ann. Neurol. 48, 817-819 https://doi.org/10.1002/1531-8249(200011)48:5<817::AID-ANA22>3.0.CO;2-S
- Nicoll, J.A., Mrak, R.E., Graham, D.I., Stewart, J., Wilcock, G., MacGowan, S., Esiri, M.M., Murray, L.S., Dewar, D., Love, S., Moss, T., and Griffin, W.S. (2000). Association of interleukin-1 gene polymorphisms with Alzheimer's disease. Ann. Neurol. 47, 365-268 https://doi.org/10.1002/1531-8249(200003)47:3<365::AID-ANA13>3.0.CO;2-G
- Pirskanen, M., Hiltunen, M., Mannermaa, A., livonen, S., Helisalmi, S., Lehtovirta, M., Koivisto, A.M., Laakso, M., Soininen, H., and Alafuzoff, I. (2002). Interleukin 1 alpha gene polymorphism as a susceptibility factor in Alzheimer's disease and its influence on the extent of histopathological hallmark lesions of Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 14,123-127 https://doi.org/10.1159/000063603
- Rebeck, G.W. (2000). Confirmation of the genetic association of interleukin-1A with early onset sporadic Alzheimer's disease. Neurosci. Lett. 293, 75-77 https://doi.org/10.1016/S0304-3940(00)01487-7
- Rosen, W.G., Terry, R.D., Fuld, P.A., Katzman, R., and Peck, A. (1980). Pathological verification of ischemic score in differentiation of dementias. Ann. Neurol. 7, 486-488 https://doi.org/10.1002/ana.410070516
- Sheng, J.G., Ito, K., Skinner, R.D., Mrak, R.E., Rovnaghi, C.R., Van Eldik, L.J., and Griffin, W.S. (1996). In vivo and in vitro evidence supporting a role for the inflammatory cytokine interleukin-1 as a driving force in Alzheimer pathogenesis. Neurobiol. Aging 7, 761-766
- Sheng, J.G., Zhu, S.G., Jones, R.A., Griffin, W.S., and Mrak, R.E. (2000). Interleukin-1 promotes expression and phosphorylation of neurofilament and tau proteins in vivo. Exp. Neurol. 163, 388-391 https://doi.org/10.1006/exnr.2000.7393
- Tsai, S.J., Liu, H.C., Liu, T.Y., Wang, K.Y., and Hong, C.J (2003). Lack of association between the interleukin-1alpha gene C(-889)T polymorphism and Alzheimer's disease in a Chinese population. Neurosci. Lett. 343, 93-96 https://doi.org/10.1016/S0304-3940(03)00333-1
- Wenham, P.R., Price, W.H., and Blandell, G. (1991). Apolipoprotein E genotyping by one-stage PCR. Lancet 337, 1158-1159